BIOMÉRIEUX ● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● Historically, the company has been releasing figures that are above expectations.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 95.9 EUR
Weaknesses
● The company's enterprise value to sales, at 4.47 times its current sales, is high.
● With an expected P/E ratio at 41.58 and 38.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The company is not the most generous with respect to shareholders' compensation.
